MYPN
Myopalladin
Also known as: MYOP, MYPN_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86TC9
- Gene
- MYPN
- Ensembl
- ENSG00000138347
- Chromosome
- 10
- Canonical length
- 1320 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Vesicles,Cytosol
OverviewNCBI Gene
Striated muscle in vertebrates comprises large proteins which must be organized properly to contract efficiently. Z-lines in striated muscle are a sign of this organization, representing the ends of actin thin filaments, titin, nebulin or nebulette and accessory proteins required for structure and function. This gene encodes a protein which interacts with nebulin in skeletal muscle or nebulette in cardiac muscle and alpha-actinin. In addition, this gene product can interact with a protein with the I-band indicating it has a regulatory as well as structural function. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2011]
Canonical amino-acid sequenceUniProt
1320 residues, UniProt reviewed canonical sequence.
>Q86TC9|MYPN
1 MQDDSIEAST SISQLLRESY LAETRHRGNN ERSRAEPSSN PCHFGSPSGA AEGGGGQDDL
61 PDLSAFLSQE ELDESVNLAR LAINYDPLEK ADETQARKRL SPDQMKHSPN LSFEPNFCQD
121 NPRSPTSSKE SPQEAKRPQY CSETQSKKVF LNKAADFIEE LSSLFKSHSS KRIRPRACKN
181 HKSKLESQNK VMQENSSSFS DLSERRERSS VPIPIPADTR DNEVNHALEQ QEAKRREAEQ
241 AASEAAGGDT TPGSSPSSLY YEEPLGQPPR FTQKLRSREV PEGTRVQLDC IVVGIPPPQV
301 RWYCEGKELE NSPDIHIVQA GNLHSLTIAE AFEEDTGRYS CFASNIYGTD STSAEIYIEG
361 VSSSDSEGDP NKEEMNRIQK PNEVSSPPTT SAVIPPAVPQ AQHLVAQPRV ATIQQCQSPT
421 NYLQGLDGKP IIAAPVFTKM LQNLSASEGQ LVVFECRVKG APSPKVEWYR EGTLIEDSPD
481 FRILQKKPRS MAEPEEICTL VIAEVFAEDS GCFTCTASNK YGTVSSIAQL HVRGNEDLSN
541 NGSLHSANST TNLAAIEPQP SPPHSEPPSV EQPPKPKLEG VLVNHNEPRS SSRIGLRVHF
601 NLPEDDKGSE ASSEAGVVTT RQTRPDSFQE RFNGQATKTP EPSSPVKEPP PVLAKPKLDS
661 TQLQQLHNQV LLEQHQLQNP PPSSPKEFPF SMTVLNSNAP PAVTTSSKQV KAPSSQTFSL
721 ARPKYFFPST NTTAATVAPS SSPVFTLSST PQTIQRTVSK ESLLVSHPSV QTKSPGGLSI
781 QNEPLPPGPT EPTPPPFTFS IPSGNQFQPR CVSPIPVSPT SRIQNPVAFL SSVLPSLPAI
841 PPTNAMGLPR SAPSMPSQGL AKKNTKSPQP VNDDNIRETK NAVIRDLGKK ITFSDVRPNQ
901 QEYKISSFEQ RLMNEIEFRL ERTPVDESDD EIQHDEIPTG KCIAPIFDKR LKHFRVTEGS
961 PVTFTCKIVG IPVPKVYWFK DGKQISKRNE HCKMRREGDG TCSLHIESTT SDDDGNYTIM
1021 AANPQGRISC SGHLMVQSLP IRSRLTSAGQ SHRGRSRVQE RDKEPLQERF FRPHFLQAPG
1081 DMVAHEGRLC RLDCKVSGLP PPELTWLLNG QPVLPDASHK MLVRETGVHS LLIDPLTQRD
1141 AGTYKCIATN KTGQNSFSLE LSVVAKEVKK APVILEKLQN CGVPEGHPVR LECRVIGMPP
1201 PVFYWKKDNE TIPCTRERIS MHQDTTGYAC LLIQPAKKSD AGWYTLSAKN EAGIVSCTAR
1261 LDIYAQWHHQ IPPPMSVRPS GSRYGSLTSK GLDIFSAFSS MESTMVYSCS SRSVVESDELLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MYPN can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 270 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 270 nTPM
- tongue: 171 nTPM
- heart muscle: 64 nTPM
- salivary gland: 2.6 nTPM
- esophagus: 2.1 nTPM
- prostate: 1.5 nTPM
Single-cell type
- myonuclei: 2,111 nCPM
- cardiomyocytes: 500 nCPM
- thymic myoid cells: 335 nCPM
- cone photoreceptor cells: 106 nCPM
- pancreatic acinar cells: 77 nCPM
- epicardial cells: 32 nCPM
Immune cell
- plasmacytoid DC: 4.4 nTPM
- NK-cell: 1.4 nTPM
- naive B-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- hippocampal formation: 1.4 nTPM
- hypothalamus: 1.3 nTPM
- medulla oblongata: 0.9 nTPM
- white matter: 0.7 nTPM
- cerebellum: 0.6 nTPM
- choroid plexus: 0.6 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MYPN.
Disease | AllUniProt
Conditions MYPN is implicated in, by any mechanism.
- Congenital myopathy 24 (CMYO24) MIM:617336
- Cardiomyopathy, dilated, 1KK (CMD1KK) MIM:615248
- Cardiomyopathy, familial hypertrophic, 22 (CMH22) MIM:615248
- Cardiomyopathy, familial restrictive 4 (RCM4) MIM:615248
Disease | GeneticClinVar
77 pathogenic / likely-pathogenic of 1,954 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Dilated cardiomyopathy 1KK
- MYPN-related myopathy
- Cardiovascular phenotype
- MYPN-related disorder
- Cardiomyopathy, familial restrictive, 4
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.51
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.13
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- axon guidance
- dendrite self-avoidance
- homophilic cell adhesion via plasma membrane adhesion molecules
- sarcomere organization
Molecular functions
- actin binding
- cell-cell adhesion mediator activity
- cytoskeletal protein binding
- muscle alpha-actinin binding
- SH3 domain binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MYPN in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MYPN as an antibody target. Whether an autoantibody or antibody against MYPN could matter depends on whether native MYPN is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MYPN is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MYPN as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...